These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Testosterone and erectile dysfunction]. Diemer T Urologe A; 2010 Jan; 49(1):26-31. PubMed ID: 20057984 [TBL] [Abstract][Full Text] [Related]
7. Testosterone therapy and cancer risk. Eisenberg ML; Li S; Betts P; Herder D; Lamb DJ; Lipshultz LI BJU Int; 2015 Feb; 115(2):317-21. PubMed ID: 24684569 [TBL] [Abstract][Full Text] [Related]
8. Androgen replacement in men with hypogonadism and erectile dysfunction. Albrecht-Betancourt M; Hijazi RA; Cunningham GR Endocrine; 2004; 23(2-3):143-8. PubMed ID: 15146093 [TBL] [Abstract][Full Text] [Related]
9. [Testosterone replacement therapy and prostate cancer: the downfall of a paradigm?]. Castillo OA; López-Fontana G; Vidal-Mora I; López Laur JD Medwave; 2015 Apr; 15(3):e6115. PubMed ID: 25919660 [TBL] [Abstract][Full Text] [Related]
10. Testosterone replacement therapy in prostate cancer patients: is it safe? Umbas R; Sugiono M Acta Med Indones; 2010 Jul; 42(3):171-5. PubMed ID: 20724773 [TBL] [Abstract][Full Text] [Related]
11. [Testosterone and the prostate]. Sperling H; Rossi R; Lümmen G; Rübben H Urologe A; 2004 Sep; 43(9):1092-6. PubMed ID: 15368045 [TBL] [Abstract][Full Text] [Related]
12. [Andropause and testosterone deficiency: how to treat in 2012?]. Renneboog B Rev Med Brux; 2012 Sep; 33(4):443-9. PubMed ID: 23091954 [TBL] [Abstract][Full Text] [Related]
13. Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects. Schubert M; Jockenhövel F J Endocrinol Invest; 2005; 28(3 Suppl):23-7. PubMed ID: 16042356 [TBL] [Abstract][Full Text] [Related]
14. The effect of testosterone replacement therapy on prostate-specific antigen (PSA) levels in men being treated for hypogonadism: a systematic review and meta-analysis. Kang DY; Li HJ Medicine (Baltimore); 2015 Jan; 94(3):e410. PubMed ID: 25621688 [TBL] [Abstract][Full Text] [Related]
15. The relationship between prostate cancer and presence of metabolic syndrome and late-onset hypogonadism. Kayali M; Balci M; Aslan Y; Bilgin O; Guzel O; Tuncel A; Atan A Urology; 2014 Dec; 84(6):1448-52. PubMed ID: 25281522 [TBL] [Abstract][Full Text] [Related]
16. Can testosterone level be a good predictor of late-onset hypogonadism? Heidari R; Sajadi H; Pourmand A; Pourmand G Andrologia; 2015 May; 47(4):433-7. PubMed ID: 24773173 [TBL] [Abstract][Full Text] [Related]
18. Testosterone treatment in the aging male: myth or reality? Nigro N; Christ-Crain M Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839 [TBL] [Abstract][Full Text] [Related]
19. The current status of therapy for symptomatic late-onset hypogonadism with transdermal testosterone gel. Ebert T; Jockenhövel F; Morales A; Shabsigh R Eur Urol; 2005 Feb; 47(2):137-46. PubMed ID: 15661407 [TBL] [Abstract][Full Text] [Related]
20. Testosterone Therapy: What We Have Learned From Trials. Corona G; Torres LO; Maggi M J Sex Med; 2020 Mar; 17(3):447-460. PubMed ID: 31928918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]